Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search…
⌘K
Search…
⌘K
← Back to rankings
AVIR
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w high -34.9%
AVIR
Atea Pharmaceuticals, Inc. Common Stock
☁️ News word cloud
Top words across the last 50 articles for this ticker.
atea
pharmaceuticals
nasdaq
2023
bemnifosbuvir
results
announced
conference
treatment
phase
clinical
data
business
therapeutics
update
high
hepatitis
antiviral
stage
trading